Page last updated: 2024-08-25

tyloxapol and n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea

tyloxapol has been researched along with n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, H; Ishikawa, E; Itokawa, S; Odaka, H; Sugiyama, Y; Tomari, Y1

Other Studies

1 other study(ies) available for tyloxapol and n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea

ArticleYear
TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
    Atherosclerosis, 1995, Volume: 118, Issue:1

    Topics: Animals; Anticholesteremic Agents; Cells, Cultured; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Dose-Response Relationship, Drug; Esterification; Intestinal Absorption; Liver; Lovastatin; Male; Mesocricetus; Phenylurea Compounds; Polyethylene Glycols; Sterol O-Acyltransferase

1995